Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale Director sold 17,915 shares at an average $29.06 ($520,694)
  2. 4 Open-market sale Chief Medical Officer sold 4,991 shares at $24.89 ($124,209)
  3. 4 Other disposition Director disposed of 3,374 shares (other)
  4. 4 Other disposition 10% owner disposed of 500,000 shares (other)
  5. 4 Other disposition Director disposed of 500,000 shares (other)
  6. 4 Open-market sale Director sold 17,915 shares at an average $25.84 ($462,976)
  7. 4 Other disposition Director disposed of 500,000 shares (other)
  8. 4 Other disposition 10% owner disposed of 500,000 shares (other)
  9. 4 Grant or award Director acquired 6,405 shares (grant or award)
  10. 4 Grant or award Director acquired 6,405 shares (grant or award)
  11. 4 Grant or award Director acquired 6,405 shares (grant or award)
  12. 4 Grant or award Director acquired 6,405 shares (grant or award)
  13. 4 Open-market sale Director sold 3,374 shares at $23.82 ($80,369)
  14. 4 Grant or award Director acquired 6,405 shares (grant or award)
  15. 4 Grant or award Director acquired 6,405 shares (grant or award)
  16. 4 Grant or award Director acquired 6,405 shares (grant or award)
  17. 4 Open-market sale Director sold 1,687 shares at $23.82 ($40,184)
  18. 4 Open-market sale Director sold 14,541 shares at $20.62 ($299,835)
  19. 4/A Other acquisition Director acquired 102,041 shares (other)
  20. 4 Open-market sale Director sold 17,915 shares at an average $20.90 ($374,424)

Page 12 of 25 · 491 filings